Analyst consensus rating
NeuroOne Medical Technologies Analyst Rating: Strong Buy
Direct answer
NeuroOne Medical Technologies's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.27.
Forecast evidence checked November 9, 2026.
Get free NeuroOne Medical Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.89
- Average price target
- $7.27
- High price target
- $8.80
- Low price target
- $5.00
- Low target gap
- +464.6%
- Target upside
- +720.6%
- High target gap
- +893.7%
- Target range width
- 429.1%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- November 9, 2026
- Valid through
- November 16, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for NeuroOne Medical Technologies?
NeuroOne Medical Technologies has a verified Strong Buy consensus. The same dataset has an average price target of $7.27.
How far are NeuroOne Medical Technologies's low and high targets from the recorded price?
The low target implies +464.6%, while the high target implies +893.7%.
How many analysts are included in NeuroOne Medical Technologies's consensus?
The verified consensus includes 3 analysts.
How is NeuroOne Medical Technologies's target upside or downside calculated?
The average target of $7.27 is divided by the recorded price of $0.89, then one is subtracted to produce +720.6%. This does not guarantee a future return.
When was NeuroOne Medical Technologies's analyst forecast verified?
The data was verified on 2026-11-09. The dataset is valid through 2026-11-16.